Articles tagged with Kinase Signaling
The foundation awarded $400,000 over two years to five early-career researchers and continuation support to three current Innovators with significant progress on their proposed research. The recipients focus on developing targeted therapeutics, decoding dendritic cell function, defining NKT cell interactions with tumors, engineering T ...
A comprehensive review synthesizes emerging evidence on AMPKα isoforms' dual roles in Alzheimer's disease. The analysis proposes that this complexity may explain why pharmacological approaches have yielded mixed results in treating the disease. Isoform-specific targeting is proposed as a novel therapeutic strategy.
Early gastric cancer cells become self-sufficient by producing WNT7B, creating a self-sustaining loop and activating WNT signaling internally. This mechanism is triggered by MAPK signaling activation and has been validated in genetically engineered mouse models and human patient-derived organoids.
Researchers at St. Jude Children's Research Hospital identified 117 kinases that can phosphorylate multiple locations within the RNA polymerase II protein tail, greatly expanding upon previous knowledge. This discovery links enzyme activity to multiple diseases, including cancer, and reveals a more integrated role for cell signaling.
A study from The University of Osaka reveals nearly half of patients with extracranial arteriovenous malformations carry mutations in the RAS/RAF/MAPK signaling pathway. These mutations were linked to abnormal vascular morphology and were frequently detected in younger female patients.
Researchers at Penn State have discovered a mechanism that resets the molecular cycle involved in the fight-or-flight response to stress and starvation. The study used imaging, structural, and biochemical techniques to uncover how this cycle completes and the system resets itself.
Researchers discovered a unique protective mechanism in pancreatic β-cells, relying on elevated levels of pro-survival proteins like cFLIP. This discovery challenges the dominant paradigm and offers new insights into diabetes research, potentially leading to novel strategies for preserving β-cell function.
GFH009 inhibits tumor growth and induces apoptosis in various HHM-derived cell lines. The compound's mechanism of action involves rapid 'on-off' inhibition of CDK9, which exerts a proapoptotic effect on cancer cells.
Researchers from Rice University and Princeton University have developed a new technology that allows for the live monitoring of signaling protein networks in living cells. The 'live reporter' system uses unobtrusive proteins to tag specific proteins, which can activate fluorescent markers when they become phosphorylated.
Researchers at RIKEN have discovered how marsupials' hearts can regenerate for several weeks after birth, allowing for potential treatment of human heart disease. They found that inhibiting a protein called AMPK extended the period of regeneration in both mice and opossums, with minimal scarring.
Researchers identified lipopolysaccharide-responsive and beige-like anchor protein (LRBA) as a crucial regulator of aquaporin-2 water channels in the kidneys. The study found that LRBA interacts with PKA to facilitate AQP2 activation, maintaining water homeostasis and preventing polyuria.
Researchers have solved the full-length structure of a crucial signaling protein in cells, known as a Janus kinase. The breakthrough could lead to new and better drugs against certain cancers, allowing healthy versions of the proteins to keep performing their normal duties.
Researchers at Thomas Jefferson University have discovered a single molecule, EphB2, that makes the yes-or-no decision to form stable connections between brain cells. The molecule repels unproductive contacts and connects where appropriate based on signal strength.